Purchase Order 75N93020P00154
- Not listed
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $19,380.00 firm fixed price purchase order is for EXPI293 Expression Medium and ExpiFectamine 293 Transfection Kit products, which support biomedical research. Life Technologies is a division of the parent company...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The contract, valued at $29,640.00, is for the provision of Freestyle 293 expression medium, a specialized cell culture product used in biomedical research. The contract does not have a set-aside designation. Life Technologies has...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The $99,558.72 contract is for the supply of "Expression Media and Medium" products and related services, with a period of performance through August 12, 2025. Life Technologies Corporation is a leading provider of...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $106,018.00 contract is for the purchase of EXPI293 expression medium over 6 scheduled shipment dates. The award does not utilize a set-aside. Life Technologies serves as a prime contractor to NIAID and other federal agencies, providing a range of...
- This is a $6,620 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for the supply of an EXPIFECTAMINE 293 Transfection Kit, a specialized reagent used in biomedical research and genetic analysis. The award does not involve any set-aside designations. Life Technologies...
- This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The $149,339.70 contract is for the provision of "293 FECTIN" products, which are likely laboratory reagents or consumables used in genetic sequencing, real-time PCR, flow cytometry, or sample preparation applications...
- This $94,612.00 Firm Fixed Price Purchase Order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of 528 units of the 293FECTIN 1ML product, a reagent used in biomedical research, with a completion date of September 30, 2012. This award did not utilize a set-aside program. Life...
- This $85,000.00 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Life Technologies Corporation (a division of Thermo Fisher Scientific) on January 25, 2017. The contract, which does not have a set-aside designation, is for the delivery of specialized biotechnology products and services to support NIAID's biomedical research and healthcare initiatives. As a...
- This $110,622.00 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for the provision of biomaterials and was not set aside. Life Technologies is a leading provider of biomedical research and genetic analysis tools and technologies to government agencies. Through this contract, the...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The contract is for the procurement of 5 Expifectamine Transfxn Reagent Kits, with a ceiling value of $23,643.00. The contract has an ultimate completion date of August 20, 2021 and was awarded on July 20, 2021. No set-aside was used...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The $24,961.30 contract is for the purchase of EXPI293 expression mediums and FREESTYLE293 expression mediums, which are likely reagents or consumables used in biomedical research and medical countermeasure development. The award does not have a set-aside designation. As a large manufacturer of scientific instruments, reagents, and services, Life Technologies has established itself as a prime contractor across multiple federal agencies, including the Departments of Defense, Agriculture, Commerce, and Justice, in addition to NIAID. Life Technologies has also participated as a subcontractor and subgrantee on various federally funded research projects, leveraging its specialized expertise in areas like genetic analysis, flow cytometry, and sample preparation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 12/18/19 |